{"version":"1.0","provider_name":"FOURNEL ADVISORY","provider_url":"https:\/\/fournel-advisory.com\/en","author_name":"Eliot Greffier","author_url":"https:\/\/fournel-advisory.com\/en\/author\/lengletremy_t0i8i26g\/","title":"ADVISORY ON CAPITAL REORGANISATION - FOURNEL ADVISORY","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"uztlQir2KV\"><a href=\"https:\/\/fournel-advisory.com\/en\/transaction\/advisory-on-capital-reorganisation\/\">ADVISORY ON CAPITAL REORGANISATION<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/fournel-advisory.com\/en\/transaction\/advisory-on-capital-reorganisation\/embed\/#?secret=uztlQir2KV\" width=\"600\" height=\"338\" title=\"&#8220;ADVISORY ON CAPITAL REORGANISATION&#8221; &#8212; FOURNEL ADVISORY\" data-secret=\"uztlQir2KV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>","thumbnail_url":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2024\/11\/ATHENA-FR.png","thumbnail_width":695,"thumbnail_height":695,"description":"FOURNEL ADVISORY\u00a0ADVISED ATHENA PHARMACEUTIQUES WITH ITS CAPITAL REORGANISATION Athena Pharmaceutiques is a recognized player in the global pharmaceutical industry, thanks to its strong commitment to the development, licensing and manufacture of solid and oral dosage forms. Athena operates through several strategic entities worldwide, including Athena Pharmaceutiques SAS, Inpharmasci and Substina in France, and Athena DDS [&hellip;]"}